Sign in
4

Changes in Ownership

abrdn Life Sciences Investors Filed Acc 0001104659-22-037465

Director bought 92.31 shares at $16.27 ($1,502)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Goetz Kathleen Director 2022-03-23 Purchase +92.31 $16.27 $1,502 685.31 D
Open-market purchases · 92.31 sh · avg $16.27 · $1,502
Loading xslF345X03/tm2210376-1_4seq1.xml…